Showing results (101-110 of 269) with videos related to
Sort By:
Pageof 27
Cytokine|September 13, 2020
Cytokine changes in sickle-cell disease patients as markers predictive of the onset of delayed hemolytic transfusion reactionsPhilippe Chadebech, Marie-Amélie de Ménorval, Gwellaouen Bodivit, et al.Internal Medicine Journal|March 1, 2019
Characteristics, risk factors and management of venous thromboembolism in immune thrombocytopenia: a retrospective multicentre studyGuillaume Le Guenno, Romain Guieze, Sylvain Audia, et al.American Journal of Hematology|January 7, 2009
Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: retrospective analysis of 27 casesGuillaume Bussone, Emmanuel Ribeiro, Agnès Dechartres, et al.American Journal of Hematology|August 19, 2016
A diagnostic nomogram for delayed hemolytic transfusion reaction in sickle cell diseaseArmand Mekontso Dessap, France Pirenne, Keyvan Razazi, et al.Plos One|February 12, 2025
Correction: Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndromeKeyvan Razazi, Enora Berti, Jerome Cecchini, et al.Research and Practice in Thrombosis and Haemostasis|February 4, 2021
ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso-occlusive crisis of sickle cell diseaseJulien Demagny, Aurélie Driss, Alain Stepanian, et al.Plos One|April 18, 2024
Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndromeKeyvan Razazi, Enora Berti, Jerome Cecchini, et al.European Journal of Immunology|March 13, 2015
Phenotypic differences of CD4(+) T cells in response to red blood cell immunization in transfused sickle cell disease patientsBenoît Vingert, Marie Tamagne, Anoosha Habibi, et al.Medicine|December 30, 2014
Environmental influences on daily emergency admissions in sickle-cell disease patientsArmand Mekontso Dessap, Damien Contou, Claire Dandine-Roulland, et al.American Journal of Blood Research|February 17, 2017
Efficacy and safety of ClairYg®, a ready-to-use intravenous immunoglobulin, in adult patients with primary immune thrombocytopeniaBorhane Slama, Olivier Fain, Hervé Maisonneuve, et al.Pageof 27